Advanced Glycation End Products (AGEs) and Diabetic Vascular Complications

E-ISSN： 1875-6417|1|1|93-106

ISSN： 1573-3998

Source： Current Diabetes Reviews, Vol.1, Iss.1, 2005-01, pp. : 93-106

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications

Recent Patents on Cardiovascular Drug Discovery, Vol. 10, Iss. 1, 2015-04 ,pp. : 10-33

Bentham Science Publishers

Access to resources Recommend Favorite

Advanced Glycation End Products (AGEs) and Cardiovascular Disease (CVD) in Diabetes

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 5, Iss. 3, 2007-07 ,pp. : 236-240

Bentham Science Publishers

Access to resources Recommend Favorite

Insulin Prevents Latent Skin Lesions by Inhibiting the Generation of Advanced Glycation End Products in Streptozotocin-Induced Diabetic Rats

By Chen Xiangfang Lin Weidong Lu Shuliang Shi Yongquan Zou Junjie Liu Zhimin Liao Wanqing

Endocrine Pathology, Vol. 20, Iss. 3, 2009-09 ,pp. : 163-169

Humana Press, Inc

Access to resources Recommend Favorite

Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina

By Hughes J. Kuiper E. Klaassen I. Canning P. Stitt A. Bezu J. Schalkwijk C. Noorden C. Schlingemann R.

Diabetologia, Vol. 50, Iss. 5, 2007-05 ,pp. : 1089-1098

Springer Publishing Company

Access to resources Recommend Favorite

Scavenger Receptors that Recognize Advanced Glycation End Products

By Miyazaki A. Nakayama H. Horiuchi S.

Trends in Cardiovascular Medicine, Vol. 12, Iss. 6, 2002-08 ,pp. : 258-262

Elsevier

Access to resources Recommend Favorite